Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking up wins against placebo and AstraZeneca’s Farxiga to stay on track to seek ...

Eli Lilly stock (NYSE: LLY) is up 10% this month, a rise driven by strong clinical trial progress. This includes the announcement of positive Phase 3 results in October 2025 for its oral GLP-1 drug, ...

Just as Adverum Biotechnologies' cash reserves were running dry, Eli Lilly has swooped in to buy the biotech and its phase 3-stage eye disease gene therapy. The prize for Lilly is ixo-vec, an ...

1925: The Goodman Theatre is founded. Timber magnate William O. Goodman and his wife donate $250,000 to the Art Institute to establish a theater and school in the name of their son, Kenneth Sawyer ...

Now four years into a first-in-class FDA approval for certain HR-positive, HER2-negative early breast cancers, Eli Lilly’s Verzenio has proven it can extend patients’ lives in the indication. Verzenio ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Morning, ...

Eli Lilly (NYSE:LLY) on Friday reported plans to acquire Adverum Biotechnologies (NASDAQ:ADVM) and its lead gene therapy candidate, Ixo-vec, sending Adverum shares soaring in premarket trading. Under ...

Oct 24 (Reuters) - Eli Lilly (LLY.N), opens new tab announced on Friday safety and efficacy results from two separate late-stage studies testing its approved drugs for alopecia and eczema. The company ...

Art museums and symphony orchestras mostly arrived in major American cities at the dawn of the 20th century. But regional theaters like the Guthrie Theatre in Minneapolis or the Alliance Theatre in ...

Eli Lilly and Company (NYSE:LLY) shares are trading lower Friday, among other GLP-1 drug manufacturers, following President Donald Trump‘s comments that fat-loss drugs will be a lot lower in price.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Lilly is looking to build four ...